Rapid inactivation of vaccinia virus in suspension and dried on surfaces.
A bioterrorist attack with smallpox virus would be disastrous with a 30% disease fatality rate. Such an outbreak would require biomedical laboratories for diagnosis and analyses and extensive use of clinical care facilities for patient quarantine. Safe decontamination procedures will have to be in place in order to limit the spread of the disease. In order to fulfil this need, Sanytex, a new non-corrosive commercial solution containing quaternary ammonium, aldehydes, alcohol and detergent, was tested with a view to using it in decontamination procedures. Vaccinia virus was used in this investigation as a model for smallpox virus. We determined exposure time and the concentration of Sanytex required to inactivate the virus in suspension and dried on surfaces in the presence of protein (up to 70 mg/mL). After 3 min incubation, Sanytex at a concentration of 3% led to a complete inactivation (virus titre reduction >10(4)-fold of vaccinia virus in suspension containing protein up to 30 mg/mL. A virus suspension containing 70 mg protein/mL, simulating biological fluids, was decontaminated with 10% Sanytex after 3 min. After 10 min, Sanytex at a concentration of 30%, applied on to a dried vaccinia virus contaminated surface in the presence of protein (10 mg/mL before desiccation), led to complete decontamination of the surface. Thirty minutes exposure with 30% Sanytex was necessary for a virus titre reduction of >10(4)-fold on a surface contaminated with a dried suspension of vaccinia virus in the presence of protein at 70 mg/mL. Sanytex is not corrosive, not toxic to environment and stable for up to three months even diluted. Its virucidal effect was preserved when used under pressure in a fire-hose nozzle. These results support the use of Sanytex for decontamination of biological fluids and surfaces contaminated by the smallpox virus.
Ferrier
A
A
Unité de Virologie, Centre de Recherches du Service de Santé des Armées (CRSSA) Emile Pardé, Grenoble, France.
Garin
D
D
Crance
J M
JM
D000438:Alcohols / Q000494:pharmacology; D000447:Aldehydes / Q000494:pharmacology; D023482:Bioterrorism; D003428:Cross Infection / Q000517:prevention & control; D003470:Culture Media; D003666:Decontamination / Q000379:methods*; D003902:Detergents / Q000494:pharmacology; D004202:Disinfectants / Q000494:pharmacology*; D004866:Equipment Contamination / Q000517:prevention & control*; D006801:Humans; D017053:Infection Control / Q000379:methods*; D050296:Microbial Viability / Q000187:drug effects*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D012899:Smallpox / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D013535:Suspensions; D014616:Vaccinia virus / Q000187:drug effects*
D000438:Alcohols; D000447:Aldehydes; D003470:Culture Media; D003902:Detergents; D004202:Disinfectants; D000644:Quaternary Ammonium Compounds; D013535:Suspensions